EDWARDS LIFESCIENCES CORPORATION vs ResMed Inc., two Medical Devices stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where EW and RMD diverge most: on fcf yield, EW reads 2.2% and RMD reads 5.7%; on ev/ebitda, EW reads 34.7 and RMD reads 14.1. The rest of the comparable metrics sit closer together. What EW's price implies is a bet that sits within the historical range (whole-company basis). What RMD's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | EW | RMD |
|---|---|---|
| Price | $86.03 | $211.00 |
| Market cap | $50.0B | $30.7B |
| Sector | Medical Devices | Medical Devices |
| Stage | Growth | Mature |
| Implied growth (priced in) | — | +11.3% |
| P/E | 45.8 | 20.4 |
| P/B | 4.84 | 4.74 |
| P/S | 7.93 | 5.55 |
| EV/EBITDA | 34.7 | 14.1 |
| Revenue growth | +14.1% | +10.3% |
| Gross margin | 78.0% | 62.3% |
| Operating margin | 29.0% | 34.9% |
| Net margin | 17.4% | 27.4% |
| Return on equity | 10.6% | 23.4% |
| Return on assets | 8.2% | 17.3% |
| Return on invested capital | 10.2% | 21.0% |
| FCF yield | 2.2% | 5.7% |
| Dividend yield | — | 1.0% |
| Debt / equity | 0.06 | 0.10 |
| Current ratio | 4.42 | 3.01 |
| Altman Z (solvency) | 8.56 | 8.30 |
| Piotroski F (quality) | 5 / 9 | 7 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.